BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1390171)

  • 1. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis.
    Berth-Jones J; Chu AC; Dodd WA; Ganpule M; Griffiths WA; Haydey RP; Klaber MR; Murray SJ; Rogers S; Jurgensen HJ
    Br J Dermatol; 1992 Sep; 127(3):266-71. PubMed ID: 1390171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis.
    Monastirli A; Georgiou S; Pasmatzi E; Sakkis T; Badavanis G; Drainas D; Sagriotis A; Tsambaos D
    Skin Pharmacol Appl Skin Physiol; 2002; 15(4):246-51. PubMed ID: 12218286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
    Dutz JP; Lui H
    Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of treatment with dithranol and calcipotriol on the clinical severity and quality of life in patients with psoriasis.
    Wall AR; Poyner TF; Menday AP
    Br J Dermatol; 1998 Dec; 139(6):1005-11. PubMed ID: 9990363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol.
    Hutchinson PE; Marks R; White J
    Dermatology; 2000; 201(2):139-45. PubMed ID: 11053917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L; Cutler TP; Helander I; Nyfors B; Downes N
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial.
    Guenther L; Van de Kerkhof PC; Snellman E; Kragballe K; Chu AC; Tegner E; Garcia-Diez A; Springborg J
    Br J Dermatol; 2002 Aug; 147(2):316-23. PubMed ID: 12174105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial.
    Veien NK; Bjerke JR; Rossmann-Ringdahl I; Jakobsen HB
    Br J Dermatol; 1997 Oct; 137(4):581-6. PubMed ID: 9390335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis.
    Van de Kerkhof PC; Green C; Hamberg KJ; Hutchinson PE; Jensen JK; Kidson P; Kragballe K; Larsen FG; Munro CS; Tillman DM
    Dermatology; 2002; 204(3):214-21. PubMed ID: 12037450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris.
    Kragballe K; Gjertsen BT; De Hoop D; Karlsmark T; van de Kerkhof PC; Larkö O; Nieboer C; Roed-Petersen J; Strand A; Tikjøb G
    Lancet; 1991 Jan; 337(8735):193-6. PubMed ID: 1670840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis.
    Salmhofer W; Maier H; Soyer HP; Hönigsmann H; Hödl S
    Acta Derm Venereol Suppl (Stockh); 2000; (211):5-8. PubMed ID: 11234559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris.
    Murdoch D; Clissold SP
    Drugs; 1992 Mar; 43(3):415-29. PubMed ID: 1374321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis.
    Tzaneva S; Hönigsmann H; Tanew A
    Br J Dermatol; 2003 Aug; 149(2):350-3. PubMed ID: 12932242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis.
    Tham SN; Lun KC; Cheong WK
    Br J Dermatol; 1994 Nov; 131(5):673-7. PubMed ID: 7999599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.
    Ortonne JP; Humbert P; Nicolas JF; Tsankov N; Tonev SD; Janin A; Czernielewski J; Lahfa M; Dubertret L
    Br J Dermatol; 2003 Feb; 148(2):326-33. PubMed ID: 12588387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of plaque-type psoriasis with the 308 nm excimer laser in combination with dithranol or calcipotriol.
    Rogalski C; Grunewald S; Schetschorke M; Bodendorf MO; Kauer F; Simon JC; Paasch U
    Int J Hyperthermia; 2012; 28(2):184-90. PubMed ID: 22335232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.